SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-16-016982
Filing Date
2016-11-29
Accepted
2016-11-29 16:29:27
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a2230395z424b5.htm 424B5 897989
2 G881334.JPG g881334.jpg GRAPHIC 8272
3 G983238.JPG g983238.jpg GRAPHIC 75718
4 G17912.JPG g17912.jpg GRAPHIC 5517
  Complete submission text file 0001047469-16-016982.txt   1022602
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214197 | Film No.: 162023048
SIC: 2834 Pharmaceutical Preparations